Centaurus Financial, Inc. Elanco Animal Health Inc Transaction History

Centaurus Financial, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$19.63 - $26.62 $4,475 - $6,069	-228 Reduced 3.72%	5,900 $116,000
Q3 2021 Nov 12, 2021	SELL	$29.2 - $36.72 $296,526 - $372,891	-10,155 Reduced 62.37%	6,128 $195,000
Q2 2021 Aug 10, 2021	BUY	$28.76 - $35.98 $6,557 - $8,203	228 Added 1.42%	16,283 $565,000
Q1 2021 Apr 30, 2021	SELL	$27.85 - $34.49 $30,635 - $37,939	-1,100 Reduced 6.41%	16,055 $473,000
Q4 2020 Jan 25, 2021	SELL	$27.53 - $33.79 $26,153 - $32,100	-950 Reduced 5.25%	17,155 $526,000
Q3 2020 Nov 12, 2020	BUY	$21.1 - $29.13 $226,930 - $313,293	10,755 Added 146.33%	18,105 $506,000
Q2 2020 Aug 13, 2020	BUY	$18.94 - $24.93 $139,209 - $183,235	7,350 New	7,350 $158,000
Q1 2020 Apr 21, 2020	SELL	$16.68 - $32.25 $72,558 - $140,287	-4,350 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$25.29 - $29.45 $110,011 - $128,107	4,350 New	4,350 $128,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.